Back to Agenda
Regulatory Affairs: Part 4: Special Regulatory Programs and Quality Assurance in Drug Development
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
Kevin Daniel Healy, PhD
Senior Vice President Regulatory Affairs
Entrada Therapeutics, United States
Regulatory Affairs: Part 4: Special Regulatory Programs and Quality Assurance in Drug Development
Have an account?